Stock ORIONINFU ORION INFUSION LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Orion Infusion Limited

Equities

ORIONINFU

BD0472ORINF6

Pharmaceuticals

End-of-day quote Dhaka S.E.
Other stock markets
 03:30:00 09/05/2024 am IST 		5-day change 1st Jan Change
624.9 BDT -2.98% Intraday chart for Orion Infusion Limited -1.48% +72.96%
07/02 Orion Infusion Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
2023 Orion Infusion Limited Recommends Cash Dividend for the Year Ended June 30, 2023 CI

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 1,195 1,169 1,468 1,395 1,777 6,851
Enterprise Value (EV) 1 1,531 1,481 1,796 1,672 2,068 7,171
P/E ratio 36.2 x 29.2 x 49.4 x 50 x 41.5 x 164 x
Yield 2.39% - 1.39% 1.46% 2.29% 0.3%
Capitalization / Revenue 1.59 x 1.44 x 1.98 x 1.92 x 2.14 x 8.46 x
EV / Revenue 2.03 x 1.83 x 2.42 x 2.3 x 2.49 x 8.85 x
EV / EBITDA 14.4 x 14.1 x 18.8 x 18.3 x 20.1 x 76.4 x
EV / FCF 179 x 27.1 x 42.9 x 22.9 x 207 x -19,176 x
FCF Yield 0.56% 3.68% 2.33% 4.36% 0.48% -0.01%
Price to Book 4.69 x 4.5 x 5.69 x 5.23 x 6.14 x 23.5 x
Nbr of stocks (in thousands) 20,360 20,360 20,360 20,360 20,360 20,360
Reference price 2 58.70 57.40 72.10 68.50 87.30 336.5
Announcement Date 25/11/18 08/11/20 08/11/20 29/11/21 27/11/22 04/11/23
1BDT in Million2BDT
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 753.8 810.3 740.9 727.4 829.6 810.2
EBITDA 1 106.2 105.1 95.65 91.16 103 93.82
EBIT 1 83.91 79.41 76.99 81.07 92.56 78.43
Operating Margin 11.13% 9.8% 10.39% 11.15% 11.16% 9.68%
Earnings before Tax (EBT) 1 41.26 50.15 38.69 52.3 65.32 50.3
Net income 1 33.04 40.09 29.7 27.88 42.82 41.9
Net margin 4.38% 4.95% 4.01% 3.83% 5.16% 5.17%
EPS 2 1.623 1.969 1.459 1.370 2.103 2.058
Free Cash Flow 1 8.545 54.54 41.84 72.89 10 -0.374
FCF margin 1.13% 6.73% 5.65% 10.02% 1.21% -0.05%
FCF Conversion (EBITDA) 8.05% 51.89% 43.74% 79.96% 9.71% -
FCF Conversion (Net income) 25.86% 136.05% 140.9% 261.42% 23.36% -
Dividend per Share 2 1.400 - 1.000 1.000 2.000 1.000
Announcement Date 25/11/18 08/11/20 08/11/20 29/11/21 27/11/22 04/11/23
1BDT in Million2BDT
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 336 312 328 278 290 320
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 3.162 x 2.968 x 3.428 x 3.047 x 2.816 x 3.415 x
Free Cash Flow 1 8.54 54.5 41.8 72.9 10 -0.37
ROE (net income / shareholders' equity) 12.9% 15.6% 11.5% 10.6% 15.4% 14.4%
ROA (Net income/ Total Assets) 7.5% 7.13% 7% 7.37% 8.09% 6.15%
Assets 1 440.5 562.4 424.4 378.1 529.6 681.2
Book Value Per Share 2 12.50 12.80 12.70 13.10 14.20 14.30
Cash Flow per Share 2 0.4500 0.4100 0.5800 0.5100 1.600 2.210
Capex 1 7.58 17.7 15.5 22.1 19.4 67.9
Capex / Sales 1.01% 2.18% 2.1% 3.04% 2.34% 8.38%
Announcement Date 25/11/18 08/11/20 08/11/20 29/11/21 27/11/22 04/11/23
1BDT in Million2BDT
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
ORION INFUSION LIMITED Stock Orion Infusion Limited
+72.96% 109M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+30.38% 684B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.36% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.30% 329B
ABBVIE INC. Stock AbbVie Inc.
+3.73% 284B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.70% 240B
NOVARTIS AG Stock Novartis AG
+8.78% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-7.93% 200B
AMGEN INC. Stock Amgen Inc.
+7.68% 166B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ORIONINFU Stock
  4. Financials Orion Infusion Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW